Date published: 2025-10-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAT4 Inhibitors

FAT4 Inhibitors represent a specialized class of chemicals that target the FAT Atypical Cadherin 4 (FAT4) protein, a crucial component in the regulation of several cellular processes. FAT4, part of the cadherin superfamily, is known for its role in cell adhesion, growth, and polarity. Inhibitors of FAT4 are designed to modulate the activity of this protein by directly interfering with its function. These chemicals typically bind to the extracellular domain of FAT4, which is crucial for its interaction with other cellular components. By binding to this domain, FAT4 inhibitors effectively prevent the protein from engaging in its normal cellular functions, such as signaling pathways that regulate cell proliferation and differentiation. The specific binding sites and modes of interaction vary among different FAT4 inhibitors, but the overarching mechanism involves the disruption of FAT4's ability to mediate cell-cell adhesion and communication. The design and development of FAT4 inhibitors draw on an understanding of the protein's structure and the critical domains necessary for its function. These inhibitors often mimic or compete with natural ligands or substrates of FAT4, thereby blocking its activity. The molecular structure of these inhibitors is tailored to ensure high affinity and specificity for FAT4, reducing the likelihood of off-target effects. The chemical properties of FAT4 inhibitors, such as solubility, stability, and bioavailability, are fine-tuned to optimize their interaction with the protein. Researchers studying these inhibitors focus on understanding the detailed molecular interactions between the inhibitor and FAT4, utilizing techniques like crystallography, molecular docking, and computational modeling. This level of analysis provides insights into the precise ways these chemicals interfere with FAT4's function, allowing for the continual refinement and improvement of inhibitor design. By targeting the distinct aspects of FAT4's role in cellular signaling, FAT4 inhibitors contribute significantly to the broader understanding of cell biology and the intricate network of protein-protein interactions.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 is a potent inhibitor of ROCK (Rho-associated protein kinase), which is involved in actin cytoskeleton organization. By inhibiting ROCK, Y-27632 can indirectly affect FAT4 signaling, which is also linked to cytoskeletal dynamics.

Thiazovivin

1226056-71-8sc-361380
sc-361380A
10 mg
25 mg
$278.00
$622.00
15
(1)

Thiazovivin is a ROCK inhibitor, similar to Y-27632. It can potentially modulate FAT4-related pathways by influencing actin cytoskeleton organization and cellular morphology.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

This compound inhibits the activation of Rac1, a GTPase involved in actin cytoskeleton remodeling. Since FAT4 is associated with cellular morphology, NSC 23766 might influence FAT4 pathways by modulating Rac1 activity.

(S)-(−)-Blebbistatin

856925-71-8sc-204253
sc-204253A
sc-204253B
sc-204253C
1 mg
5 mg
10 mg
25 mg
$71.00
$260.00
$485.00
$949.00
(2)

Blebbistatin is an inhibitor of non-muscle myosin II, which plays a role in cell motility and shape. Its inhibition could indirectly affect FAT4 signaling pathways related to cell adhesion and movement.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. As this pathway can be linked to cadherin-mediated signaling, it may have an indirect impact on FAT4 function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

This compound is an inhibitor of JNK, part of the MAPK pathway. By affecting JNK, SP600125 may influence FAT4-related signaling, particularly in stress responses and apoptosis.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor. Since PI3K is involved in various signaling pathways, including those related to cell adhesion and migration, it could indirectly impact FAT4 pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Similar to LY294002, Wortmannin is a PI3K inhibitor. Its influence on PI3K-Akt signaling can indirectly affect FAT4-related processes, particularly in cell survival and migration.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation. Since mTOR signaling can intersect with pathways involving FAT4, Rapamycin could have an indirect effect.